Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02430376 · ClinicalTrials.gov registry record
dbGaP Protocol: Genetic Variants Associated With Pentalogy of Cantrell
A clinical trial of Pentalogy of Cantrell, sponsored by National Heart, Lung, and Blood Institute (NHLBI).
- Completed
- Registry status
- 3,280
- Enrollment target
- 1
- Study location
NCT02430376: Completed study of Pentalogy of Cantrell, sponsored by National Heart, Lung, and Blood Institute (NHLBI).
NCT02430376 is a study of Pentalogy of Cantrell that has completed, run by National Heart, Lung, and Blood Institute (NHLBI). The registered enrollment target is 3,280 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02430376, a study of Pentalogy of Cantrell, has completed, sponsored by National Heart, Lung, and Blood Institute (NHLBI).
- COMPLETED
- Registry status
- 3,280 participants
- Enrollment target
- 1
- Study location
Study Summary
Background: Pentalogy of Cantrell (POC) is a syndrome that involves many heart abnormalities as well as large defects in the chest and abdominal wall. This often results in the heart and other organs being present outside the body at birth. Surgeons have learned to replace them and repair the heart. Researchers want to find possible gene changes that cause POC. To do this, they want to study data from the Pediatric Cardiovascular Genetics Consortium (PCGC) Cohort. The PCGC collects data and DNA samples from people with heart diseases and their families Objectives: \- To find gene mutations in people with Pentalogy of Cantrell (POC) or other related syndromes. Eligibility: \- PCGC data and DNA samples that are open to study by the public. Design: * Researchers will study the data from the PCGC. * The gene testing being done in this study was consented to in the original studies. No new consent or waiver request is required. * The study will last 1 year.
Conditions Studied
Study Locations (1)
Maryland
- National Institutes of Health Clinical Center, 9000 Rockville Pike - Bethesda
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,280 participants |
| Start Date | 2015-04-25 |
| Est. Completion | 2016-03-23 |
What the finished NCT02430376 record still lists
NCT02430376 is an observational study that tracks outcomes without assigning an intervention. Its 3,280 participants enrollment target places it among the larger protocols in the corpus.
The record links to 1 condition, with Pentalogy of Cantrell appearing as the primary indexed condition, and to 0 interventions.
NCT02430376 reports a single indexed study location in Maryland.
Frequently Asked Questions
What is clinical trial NCT02430376 about?
NCT02430376 is a clinical study titled "dbGaP Protocol: Genetic Variants Associated With Pentalogy of Cantrell". Background: Pentalogy of Cantrell (POC) is a syndrome that involves many heart abnormalities as well as large defects in the chest and abdominal wall. This often results in the heart and other organs being present outside the body at birth. Surgeons have learned to replace them and repair the heart...
What is the current status of trial NCT02430376?
This trial is currently completed. The enrollment target is 3,280 participants. The study started on 2015-04-25. Estimated completion is 2016-03-23.
What conditions does trial NCT02430376 study?
This clinical trial studies the following conditions: Pentalogy of Cantrell.
Who is sponsoring clinical trial NCT02430376?
This trial is sponsored by National Heart, Lung, and Blood Institute (NHLBI), which has 501 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02430376 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pentalogy of Cantrell
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06543446 · 3,290 participants · NA
Comparative Effectiveness of Prophylactic ICD Versus Non-ICD Therapy
- NCT06815536 · 3,291 participants
Master Protocol for Evaluating Multiple Infection Diagnostics for Ciprofloxacin-Resistant Neisseria Gonorrhoeae
- NCT04077762 · 3,266 participants · NA
Radial Vs. State-Of-The-Art Femoral Access for Bleeding and Access Site Complication Reduction in Cardiac Catheterization (REBIRTH)
- NCT07214610 · 3,300 participants · NA
Integrating Biological, Clinical, and Behavioral Factors to Improve Breast Cancer Outcomes - Carolina Breast Cancer Study
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI